U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193693) titled 'Barriers Limiting OCT Penetration in Clinical Practice' on Sept. 10.
Brief Summary: The updated guidelines from the European Society of Cardiology (ESC) for chronic coronary syndrome (CCS) have upgraded the use of IVUS and OCT to a class IA recommendation for complex PCI, based on evidence showing a reduction in serious clinical events, including mortality, compared to conventional angiography alone. Despite this, IVUS and OCT are underutilized in daily practice due to factors such as time, cost, and limited technology availability. Investigating the reasons behind this underuse is necessary, especially now that these technologies ...